Label: Information for the User
Simvastatina MABO-FARMA 10 mg Film-Coated Tablets
Read this label carefully before you start taking this medicine, because it contains important information for you.
Simvastatina is a medication used to reduce total cholesterol, "bad" cholesterol (low-density lipoprotein, LDL) and certain fatty substances called triglycerides that circulate in the blood. Additionally, simvastatina increases the levels of "good" cholesterol (high-density lipoprotein, HDL). Simvastatina is a member of a class of medications called statins.
Cholesterol is one of the fatty substances found in the bloodstream. Its total cholesterol is composed mainly of LDL and HDL.
LDL cholesterol is often referred to as "bad" cholesterol because it can accumulate in the walls of arteries forming plaques. Over time, this accumulation of plaque can cause artery narrowing. This narrowing can slow down or interrupt blood flow to vital organs such as the heart and brain. This interruption of blood flow can cause a myocardial infarction or a stroke.
HDL cholesterol is often referred to as "good" cholesterol because it helps prevent bad cholesterol from accumulating in arteries and protects them from cardiovascular diseases.
Triglycerides are another type of fat in your blood that can increase the risk of heart disease. While taking this medication, you must follow a cholesterol-reducing diet.
Simvastatina is used, along with a cholesterol-reducing diet, if you have:
Most people do not have immediate symptoms of high cholesterol. Your doctor may measure your cholesterol with a simple blood test. Visit your doctor regularly, monitor your cholesterol, and discuss your goals with your doctor.
Do not take Simvastatina Mabo-Farma:
Consult your doctor if you are unsure if your medication is on this list.
Warnings and precautions
Inform your doctor:
Your doctor will perform a blood test before you start taking simvastatin and also if you have any symptoms of liver problems while taking this medication. This is to check how well your liver is working.
Your doctor may also want to perform blood tests to check how well your liver is working after you start taking simvastatin.
Your doctor will monitor if you have diabetes or are at risk of developing diabetes. This risk of diabetes increases if you have high levels of sugar and fat in your blood, overweight, and high blood pressure.
Inform your doctor if you have a severe lung disease.
Consult your doctor immediately if you experience:
Dullness, sensitivity to pressure, or unexplained muscle weakness. This is because, in rare cases, muscle problems can be severe, including muscle failure, which can cause kidney damage; and very rarely, deaths have occurred.
The risk of muscle failure is higher with high doses of simvastatin, especially with a dose of 80 mg. The risk of muscle failure is also higher in certain patients. Talk to your doctor if any of the following situations affect you:
Also inform your doctor or pharmacist if you experience persistent muscle weakness. Further tests and additional medications may be necessary to diagnose and treat this condition.
Children and adolescents
The efficacy and safety of simvastatin treatment were studied in boys aged 10 to 17 years and in girls who had their first menstrual period (menstruation) at least one year earlier (see section 3. How to take Simvastatina Mabo-Farma). Simvastatin has not been studied in children under 10 years of age. For more information, consult your doctor.
Other medications and Simvastatina Mabo-Farma
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication. Taking this medication with any of the following medications may increase the risk of muscle problems (some of which are already included in the section above "Do not take Simvastatina Mabo-Farma").
As with the medications listed above, inform your doctor or pharmacist if you are taking or have taken recently other medications, even those purchased without a prescription. In particular, inform your doctor if you are taking medications with any of the following active ingredients:
You should also inform any doctor who prescribes a new medication that you are taking this medication.
Simvastatina Mabo-Farma with food and drinks
Orange juice increases simvastatin levels in the blood. You should avoid consuming orange juice while taking simvastatin.
Simvastatin should be administered with caution in patients who consume alcohol. If you regularly drink alcohol, consult your doctor.
Pregnancy and breastfeeding
Do not take this medication if you are pregnant, trying to become pregnant, or think you may be pregnant. If you become pregnant while taking simvastatin, stop taking it immediately and inform your doctor. Do not take this medication if you are breastfeeding, as it is unknown whether this medication passes into breast milk.
Consult your doctor or pharmacist before using any medication.
Driving and operating machinery
Simvastatin is not expected to interfere with your ability to drive or operate machinery. However, some people may experience dizziness after taking simvastatin.
Simvastatina Mabo-Farma contains lactose
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Followexactly the administration instructions for this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The tablets should be taken at night and can be administered with water or with or without food.
Before starting to take this medication, you should be following a diet to reduce cholesterol.
The recommended starting dose is10 to40 mg per day, administered in a single dose at night.
Your doctor may adjust your dose up to a maximum of 80 mg per day, administered in a single dose at night. Do not take more than 80 mg per day.
Your doctor may prescribe lower doses, especially if you are taking certain medications indicated earlier or have certain kidney disorders.
The 80 mg dose is only recommended for adult patients with very high cholesterol levels and a high risk of heart disease problems who have not achieved their cholesterol goal with lower doses.
Use in children and adolescents
In children and adolescents aged 10 to 17 years, the recommended daily starting dose for treatment is 10 mg, at night. The maximum recommended daily dose is 40 mg.
Administration method:
Take simvastatin at night. You can take it with or without food. Continue taking simvastatin until your doctor tells you to stop.
If your doctor has prescribed simvastatin along with another cholesterol-lowering medication that contains a bile acid sequestrant, you should take simvastatin at least 2 hours before or 4 hours after taking the bile acid sequestrant.
Use in elderly patients
No dose adjustment is necessary.
If you estimate that the effect of this medication is too strong or too weak, inform your doctor or pharmacist.
If you take more Simvastatina Mabo-Farma than you should
If you forgot to take Simvastatina Mabo-Farma
Remember to take your medication.
Do not take a double dose to compensate for the missed doses. The next day, take your usual amount of simvastatin at the usual time.
If you interrupt treatment with Simvastatina Mabo-Farma
Talk to your doctor or pharmacist because your cholesterol may rise again.
If you have any other questions about the use of this medication, consult your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
These side effects may occur with certain frequencies, which are defined as follows:
If any of the serious side effects mentioned below occur, stop taking the medicine and inform your doctor immediately or go to the nearest hospital emergency service.
The following serious side effects have been reported:Rare:
The following serious side effects have been reported:Very rare:
Rarely, the following side effects have also been reported:
The following side effects have also been reported, but the frequency cannot be estimated from the available data:Unknown frequency:
Myasthenia oculis (a disease that causes weakness of the eye muscles).
Consult your doctor if you experience weakness in your arms or legs that worsens after periods of activity, double vision, eyelid drooping, difficulty swallowing, or difficulty breathing
Possible additional side effects reported with some statins:
Additional tests:
Rare:Increased levels in the blood of transaminases, alkaline phosphatase, and creatine kinase (CK).
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:http://www.notificaram.es.By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Store below 30°C.
Unused medications should not be disposed of through drains or in the trash. Dispose of packaging and unused medications at the SIGRE collection pointat the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and unused medications. By doing so, you will help protect the environment..
The other components (excipients) are:
Core: lactose monohydrate, microcrystalline cellulose, pregelatinized cornstarch, butylated hydroxyanisole (E-320), citric acid, anhydrous colloidal silica, talc, and magnesium stearate,
Coating: hydroxypropylmethylcellulose (hypromellose), red iron oxide (E-172), yellow iron oxide (E-172), triethyl citrate, titanium dioxide (E-171), and povidone K30.
Appearance of the product and contents of the package
Simvastatina Mabo-Farma 10 mgis presented in the form of film-coated tablets, intense pink in color, oval, biconvex, and scored on one of its faces.
Each package contains28tablets.
Holder of the marketing authorization
Calle Rejas 2, planta 1
28821 Coslada (Madrid)
Responsible for manufacturing
INDUSTRIA QUIMICA Y FARMACEUTICA VIR, S.A.,
C/Laguna 66-70.Polígono Industrial URTINSA II
28923 Alcorcón (Madrid) España
JABA RECORDATI, S.A.
Address:Rua da Tapada Grande nº 2, Abrunheira <|start_header_id|><|start_header_id|> The other components (excipients) are: Core: lactose monohydrate, microcrystalline cellulose, pregelatinized cornstarch, butylated hydroxyanisole (E-320), citric acid, anhydrous colloidal silica, talc, and magnesium stearate, Coating: hydroxypropylmethylcellulose (hypromellose), red iron oxide (E-172), yellow iron oxide (E-172), triethyl citrate, titanium dioxide (E-171), and povidone K30. Appearance of the product and contents of the package Simvastatina Mabo-Farma 10 mgis presented in the form of film-coated tablets, intense pink in color, oval, biconvex, and scored on one of its faces. Each package contains28tablets. Holder of the marketing authorization Calle Rejas 2, planta 1 28821 Coslada (Madrid) Responsible for manufacturing INDUSTRIA QUIMICA Y FARMACEUTICA VIR, S.A., C/Laguna 66-70.Polígono Industrial URTINSA II 28923 Alcorcón (Madrid) España JABA RECORDATI, S.A. Address:Rua da Tapada Grande nº 2, Abrunheira <|start_header_id|><|start_header_id|> The other components (excipients) are: Core: lactose monohydrate, microcrystalline cellulose, pregelatinized cornstarch, butylated hydroxyanisole (E-320), citric acid, anhydrous colloidal silica, talc, and magnesium stearate, Coating: hydroxypropylmethylcellulose (hypromellose), red iron oxide (E-172), yellow iron oxide (E-172), triethyl citrate, titanium dioxide (E-171), and povidone K30. Appearance of the product and contents of the package Simvastatina Mabo-Farma 10 mgis presented in the form of film-coated tablets, intense pink in color, oval, biconvex, and scored on one of its faces. Each package contains28tablets. Holder of the marketing authorization Calle Rejas 2, planta 1 28821 Coslada (Madrid) Responsible for manufacturing INDUSTRIA QUIMICA Y FARMACEUTICA VIR, S.A., C/Laguna 66-70.Polígono Industrial URTINSA II 28923 Alcorcón (Madrid) España JABA RECORDATI, S.A. Address:Rua da Tapada Grande nº 2, Abrunheira Fecha de la última revisión de este prospecto: abril 2023 The detailed and updated information of this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.